http://www.law360.com/ Latest articles for organization: Rite Aid Copyright 2009 Portfolio Media, Inc. en-US http://www.law360.com/images/headings/logo.gif http://www.law360.com/ http://www.law360.com/articles/133506 A federal judge allowed some claims to go forward Tuesday in multidistrict litigation that targets baby bottle and “sippy cup” makers over their use of bisphenol A, saying the companies cannot escape liability because the U.S. Food and Drug Administration has determined that the chemical may safely be used as a food additive. http://www.law360.com/articles/133506 http://www.law360.com/articles/128994 Drugstore chain Rite Aid Corp. announced Monday an offering of $250 million in senior unsecured notes as part of a plan to refinance all its debt due to mature in 2010. http://www.law360.com/articles/128994 http://www.law360.com/articles/127375 Rite Aid Corp. has moved to dismiss a putative overtime class action filed by a former drugstore employee, saying it is identical to another class action filed earlier. http://www.law360.com/articles/127375 http://www.law360.com/articles/126071 Rite Aid Corp. has asked a federal court to approve a $6.9 million settlement that would bring an end to a protracted class action accusing the drugstore chain of failing to pay its managers for overtime work. http://www.law360.com/articles/126071 http://www.law360.com/articles/124772 Plaintiffs are seeking to obtain class status in a multidistrict litigation accusing Pfizer Inc. and its Warner-Lambert Co. subsidiary of using patent litigation to postpone generic competition for epilepsy treatment Neurontin. http://www.law360.com/articles/124772 http://www.law360.com/articles/121652 Abbott Laboratories has asked a judge to throw out four recently amended complaints filed by pharmacies, wholesale direct drug purchasers and rival drug manufacturers alleging Abbott illegally jacked up the prices of its market-dominating HIV drugs, calling the complaints “a vain attempt to plead around” recent antitrust case law. http://www.law360.com/articles/121652 http://www.law360.com/articles/120479 A Bronx, N.Y., former drugstore employee has filed a putative class action against Rite Aid Corp., claiming the national chain failed to pay her overtime. http://www.law360.com/articles/120479 http://www.law360.com/articles/119788 Walgreen Co., Safeway Inc. and three others have become the latest retailers to accuse Cephalon Inc. of striking illegal deals with generic-drug makers to keep a copycat version of narcolepsy drug Provigil off the market. http://www.law360.com/articles/119788 http://www.law360.com/articles/119373 A federal judge has cleared the way for the multidistrict litigation alleging Pfizer Inc. and its Warner-Lambert Co. subsidiary engaged in a scheme to use patent litigation to delay generic competition for the epilepsy drug Neurontin to move forward. http://www.law360.com/articles/119373 http://www.law360.com/articles/117786 A federal appeals court has rejected a bid for an en banc rehearing of its decision to limit a settlement to $10 million in a class action alleging that Abbott Laboratories illegally jacked up the prices of its market-dominating HIV drug Norvir, sticking to its finding that the plaintiffs failed to state a claim in light of recent case law. http://www.law360.com/articles/117786 http://www.law360.com/articles/117780 Pharmacy chains including Rite Aid Corp. and CVS Caremark Corp. have waded into the antitrust litigation against Cephalon Inc., filing a complaint over the pharmaceutical company's alleged conspiracy with generics makers to keep narcolepsy drug Provigil off the market. http://www.law360.com/articles/117780 http://www.law360.com/articles/116561 Rite Aid Corp., CVS Pharmacy Inc. and several other pharmacy chains have filed a second amended complaint in their antitrust action against Abbott Laboratories alleging the drugmaker illegally jacked up the prices of its market-dominating HIV medications, following an appeals court ruling that a similar class action against Abbott failed to state a valid claim in light of recent case law. http://www.law360.com/articles/116561 http://www.law360.com/articles/116311 Several candy makers received a sweet deal recently when they were dismissed from the multidistrict litigation over alleged price-fixing in the market for chocolate confectionery products after a federal judge agreed with their contention that the U.S. courts do not have jurisdiction over them. http://www.law360.com/articles/116311 http://www.law360.com/articles/112877 A group of assistant store managers has hit Rite Aid Corp. and subsidiary Eckerd Corp. with a putative class action under the Ohio Minimum Fair Wage Standards Act, claiming the managers were unfairly exempted from overtime pay. http://www.law360.com/articles/112877 http://www.law360.com/articles/108932 Safeway Inc. and Walgreen Co. have sued five drug companies — including Solvay Pharmaceuticals Inc. and its unit Unimed Pharmaceuticals LLC — over an alleged scheme to block generic competition for the drug AndroGel, marking another private suit over AndroGel in the wake of the Federal Trade Commission taking Solvay to court in January. http://www.law360.com/articles/108932 http://www.law360.com/articles/101377 Infant formula maker PBM Products LLC has asked a federal court to bar Nestle SA and its Gerber Products Co. unit from using the trademarks "gentle" or "gentle plus" to sell baby formula while PBM pursues its case accusing the Swiss company of infringing the three-year-old mark. http://www.law360.com/articles/101377 http://www.law360.com/articles/99479 Former Heller Ehrman LLP client Ronald A. Katz Technology Licensing LP has filed a $50 million claim against the bankrupt firm, alleging that by shutting down, Heller breached an agreement to represent Katz in numerous patent suits. http://www.law360.com/articles/99479 http://www.law360.com/articles/98482 A federal judge has approved a $250 million settlement in the long-running antitrust class action that accused Abbott Laboratories and its French partner Fournier Industrie et Sante of conspiring to block generics makers from breaking into the lucrative market for the high-cholesterol drug TriCor. http://www.law360.com/articles/98482 http://www.law360.com/articles/96363 In multidistrict litigation over alleged price-fixing in the chocolate industry, a federal judge has agreed to allow a group of chocolate makers to immediately appeal a recent ruling that the plaintiffs' claims had sufficiently cleared a hurdle put in place by the Supreme Court in Bell Atlantic Co. v. Twombly. http://www.law360.com/articles/96363 http://www.law360.com/articles/95434 A federal judge has dismissed a consolidated class action accusing Pfizer Inc. of a scheme to use patent litigation to delay generic competition for the epilepsy drug Neurontin, after the end-payor plaintiffs voluntarily dropped their claims against the pharmaceutical giant. http://www.law360.com/articles/95434